SciGen, Ltd., a Singapore company that trades in Australia, has licensed the China rights to Oral-lyn™, an oral insulin spray product that is being developed by Generex. SciGen will supply its own recombinant human insulin product, while Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the territory. More details...

Stock Symbols: (ASX: SIE) (NSDQ: GNBT)